China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 8 | 4 | −4 |
| Shares | 480.5K | 50.5K | −430.0K (−89.5%) |
| Value | $57.0K | $199.4K | +$142.3K (+249.6%) |
New holders (1)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marex Group plc | 41,293 | $163.9K | 0.01% |
Sold out (5)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Citadel Advisors LLC | 191,339 | $23.5K |
| Two Sigma Securities, LLC | 49,965 | $6.15K |
| Level Four Advisory Services, LLC | 42,771 | $5.26K |
| HRT Financial LP | 48,507 | $5.00K |
| Baader Bank INC | 12,916 | $1.42K |